April 2009 | Michael R. Stratton, Peter J. Campbell & P. Andrew Futreal
The article discusses the role of mutations in cancer genomes and their implications for cancer development. It outlines how cancer arises from genetic changes in DNA, and how these mutations contribute to the development of various cancers. The text explains that cancer is an evolutionary process, where cells undergo genetic changes that allow them to proliferate and survive. It describes the types of mutations that can occur in cancer genomes, including point mutations, copy number changes, and genomic rearrangements. The article also differentiates between driver and passenger mutations, where driver mutations contribute to cancer development, while passenger mutations do not. It highlights the importance of identifying driver mutations in cancer research and the challenges involved in distinguishing them from passenger mutations. The text also discusses the identification of cancer genes and the impact of mutations on cancer progression. It emphasizes the importance of sequencing cancer genomes to understand the genetic basis of cancer and to develop targeted therapies. The article concludes with the potential of large-scale sequencing efforts to provide a comprehensive understanding of cancer genomes and to improve cancer treatment.The article discusses the role of mutations in cancer genomes and their implications for cancer development. It outlines how cancer arises from genetic changes in DNA, and how these mutations contribute to the development of various cancers. The text explains that cancer is an evolutionary process, where cells undergo genetic changes that allow them to proliferate and survive. It describes the types of mutations that can occur in cancer genomes, including point mutations, copy number changes, and genomic rearrangements. The article also differentiates between driver and passenger mutations, where driver mutations contribute to cancer development, while passenger mutations do not. It highlights the importance of identifying driver mutations in cancer research and the challenges involved in distinguishing them from passenger mutations. The text also discusses the identification of cancer genes and the impact of mutations on cancer progression. It emphasizes the importance of sequencing cancer genomes to understand the genetic basis of cancer and to develop targeted therapies. The article concludes with the potential of large-scale sequencing efforts to provide a comprehensive understanding of cancer genomes and to improve cancer treatment.